ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors.

Pamela N Munster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.